Michaela Prchal‐Murphy

CDK6 as a key regulator of hematopoietic and leukemic stem cell activation

Ruth Scheicher, Andrea Hoelbl‐Kovacic, Florian Bellutti et al. · Blood · 2014 · 279 citations · Full text

Life Sciences, Cell Biology, Hematology +14

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy

Edit Porpaczy, Sabrina Tripolt, Andrea Hoelbl‐Kovacic et al. · Blood · 2018 · 154 citations · Full text

Medicine, Hematology, Immunology +14

STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion

Dagmar Gotthardt, Eva Maria Putz, Eva Grundschober et al. · Cancer Discovery · 2016 · 150 citations

Life Sciences, Immunology, Oncology +17

Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6

Iris Z. Uras, Gina Walter, Ruth Scheicher et al. · Blood · 2016 · 148 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +16

STAT5BN642H is a driver mutation for T cell neoplasia

Hà Phạm, Barbara Maurer, Michaela Prchal‐Murphy et al. · Journal of Clinical Investigation · 2017 · 87 citations · Full text

Medicine, Molecular Biology, Oncology +17